$0.7810
-0.083-9.61%
Last update: Oct 23, 6:54 PM
Dermata Therapeutics Inc (DRMA) Stock Price, Quote, News & History
DRMANASDAQ
Dermata Therapeutics (DRMA) jumps 34% after positive clinical results for its weekly Bioneedle Tome Foundational Treatment.
You can purchase shares of Dermata Therapeutics (NASDAQ:DRMA) through any online brokerage.
Other companies in Dermata Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Dermata Therapeutics has a consensus price target of $10.00.
The stock price for Dermata Therapeutics (NASDAQ: DRMA) is $0.7523 last updated October 23, 2026 at 6:54 PM EDT.
There are no upcoming dividends for Dermata Therapeutics.
Dermata Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Dermata Therapeutics.
Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis,...
